Have Asthma?

Protocol # CCD-05993AA3-01

You may qualify for a local ASTHMA research study now enrolling

 

POTENTIAL STUDY SUBJECT’S WILL NEED TO BE:

          -Male or female subjects aged ≥18 and ≤75 years

          - A diagnosis of asthma for at least 1 year prior to screening

          - Poorly controlled or uncontrolled moderate asthma

          - Use of a stable dose of ICS (low/medium dose) for 3 months before

            Screening visit

• Investigational ASTHMA study medication and standard of care   

   Medication for ASTHMA at no cost 

• Study-related care from a local doctor

• Compensation for travel

You may contact our office at Chesapeake Clinical Research, Inc.

(410)-931-1966 Ext 113 or visit www.chesapeakecr.com for more information.

Chiesi Farmaceutici S.p.A. Via Palermo 26/A 43122 Parma – Italy

Protocol # CCD-05993AA3-01

Principal Investigator: Dr. Jonathan Matz, M.D.